Cargando…
Mammary Carcinoma Cell Derived Cyclooxygenase 2 Suppresses Tumor Immune Surveillance by Enhancing Intratumoral Immune Checkpoint Activity
INTRODUCTION: Systemic inhibition of the inflammatory enzyme cyclooxygenase (COX) 2 decreases the risk of breast cancer and its recurrence. However, the biology of COX-2 in the multicellular tumor microenvironment is poorly defined. METHODS: Mammary tumor onset and multiplicity were examined in ErbB...
Autores principales: | Markosyan, Nune, Chen, Edward P, Evans, Rebecca A, Ndong, Victoire, Vonderheide, Robert H, Smyth, Emer M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979159/ https://www.ncbi.nlm.nih.gov/pubmed/24004819 http://dx.doi.org/10.1186/bcr3469 |
Ejemplares similares
-
Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance
por: Markosyan, Nune, et al.
Publicado: (2014) -
Editorial: Eicosanoids in Cancer
por: Markosyan, Nune, et al.
Publicado: (2021) -
Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
por: Liu, Bing, et al.
Publicado: (2015) -
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade
por: Onieva, Juan Luis, et al.
Publicado: (2022) -
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
por: Zhang, Yumeng, et al.
Publicado: (2022)